**Gain the Decision Advantage**

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

## [The Future of Pharmacovigilance Analytics and Insight](/content/blogs/future-pharmacovigilance-analytics-insight/index.html)

What will the next generation of reporting and analytics in ...

## [Real-World Data: From Dream to Reality](/content/blogs/real-world-data-dream-to-reality/index.html)

Concepts once thought to be theoretical are now a reality ...

## [Unlocking the Next Generation of Reporting and Analytics for Drug Safety Intelligence](/content/blogs/reporting-and-analytics-in-safety-case-management/index.html)

The Future of Drug Safety Intelligence The future of safety ...

## [Setting a New Standard in Safety Signal Analytics](/content/blogs/safety-signal-analytics-launch/index.html)

ArisGlobal Announces the Launch of LifeSphere Clarity  As a pharmacovigilance ...

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.